Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The world market for epigenetics is expected to reach $18.2bn by 2015, according to a report by Global Industry Analysts (GIA).
Subscribe to our email newsletter
The growth is primarily driven by exploration of factors influencing cellular malfunction and disease development. Additionally, innovations in epigenetic studies such as biomarker discovery and scientifically useful biomarker tests are expected to contribute to the market growth.
According to GIA, epigenetics represents a rapidly growing field in the biological sciences industry. Biological researchers are increasingly attempting to discover the process of cells exploiting the information programmed in the genome. Epigenetics is the study of the regulation of mechanisms other than DNA sequence over the genomic information programmed in the DNA sequence.
All those non-DNA sequence components are highly influential on gene expressions by switching genes off and on. The means of epigenetics are integral to general development and linked with disorders and diseases. Recent findings in this area are expected to bring about major applications in the healthcare and treatment of diseases in the long term.
Most of the attention in the epigenetic research and development is devoted to DNA methylation, the histone changes as biomarkers have recently drawn attention. Advances in technology and science are driving this surge. Researchers are obtaining a firm base in gaining knowledge about histone changes that affect health and disorders. This knowledge is a key ingredient of the supposed histone code theory.
New revelations in throughput genomic epigenetic recognition methods that are enabled by the new deep sequencing technologies appear to the useful in histone decoding. Following the finding of its epigenetic effect, physicians studied its application in other fields.
Stem cells also represent an enthusiastic area in epigenetics. The study of epigenetic alterations that regulate the cell development enables researchers to determine the type of tissue a stem cell turns into. Epigenetic features possibly play a major role in temporary adaptation of species through the use of reversible phenotype variability.
The changes which take place in epigenetic features linked with a particular region of DNA permit organisms, measuring over a multigenerational time scale, to swap among phenotypes which express and repress that particular gene.
Key players profiled in the report titled ‘Epigenetics: A Global Strategic Business Report’ include Celgene, CellCentric, Epigenomics, Epigentek Group, Genpathway, Merck & Co, MGI Pharma, Millipore, OncoMethylome Sciences, and Orion Genomics.